Consistent with the gene trap model, the reduction of Resf1 by CRISPR-mediated deletion was associated with increased tumor burden, more rapid tumor growth, and an increase in the number of pulmonary metastases (S3A–S3D Fig). This evidence concerns the gene RESF1 and neoplasm.